Introduction:Â Women who are pregnant or who could become pregnant experience delayed access to or underinformed use of important new antiretroviral (ARV) drugs because of traditional drug development processes that ostensibly aim to reduce potential harm but...
Abstract Introduction Historical approaches to clinical development of novel therapeutics for treatment and prevention of HIV have led to unacceptable delays in the generation of data to support optimal antiretroviral drug use in pregnancy. Over the last 5 years,...
Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...
Hatcher AM, Brittain K, Phillips TK, Zerbe A, Abrams EJ, Myer L. Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women. AIDS. 2021 Apr 1;35(5):791-799. doi: 10.1097/QAD.0000000000002796....
Teasdale CA, Geller A, Shongwe S, Mafukidze A, Choy M, Magaula B, Yuengling K, King K, De Gusmao EP, Ryan C, Ao T, Callahan T, Modi S, Abrams EJ. Â PLoS One. 2021 Mar 24;16(3):e0248685. doi: 10.1371/journal.pone.0248685. PMID: 33760864. Abstract Background:Â Uptake and...
